BioSpace News Archive

BioPharm International®, a digital resource of technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology and bioprocessing, will host a live webcast titled “From Small-Scale Stem Cell Production to Large-Scale hiPSC-Based Drug Development: The Flexibility of Stirred-Tank Bioreactors” on Monday, Sept. 16, at 9 a.m. EDT, 2 p.m.

Transaction Expands Presence in Rapidly Growing Arizona and Florida Markets

Novel Therapeutic Shows Remarkable Efficacy in HepG2 Cell Lines

RNA whole-transcriptome sequencing test informs thyroid cancer treatment decisions at time of diagnosis

Key Clinical Research Opinion Leader to Address Alternate Therapy Strategies for the Opioid Crisis

The retro-fit solution is not limited to door access only, its capabilities can also be implemented in data centers, IDF & MDF closets, server cabinets, machinery, vaults, and other equipment to provide additional step-up authentication security without requiring the replacement of existing access control systems, readers or cards.

C4 Imaging LLC is pleased to announce the first prostate cancer treatment utilizing Orion™, a novel medical device that’s designed to facilitate the use of MRI in improving the accuracy of treatment.

Vifor Pharma announced changes to its management. Dr Klaus Henning Jensen will join the company as Chief Medical Officer and Member of the Executive Committee in January 2020.

VitalTech™ announced the closing of their Series A financing round from two strategic investors: Concord Health Partners, a healthcare focused investment firm, and Stanley Ventures, the investment arm of Stanley Black & Decker.

According to Morgan Stanley Capital International’s latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry.